What smart money is saying about EKF Diagnostics
EKF.L
No fund has written a full thesis on EKF Diagnostics in our archive, but 1 fund letter reports a position in it — most recently Liontrust UK Smaller Companies Fund in July 2026.
Get an email when a fund writes about it
1
Reported positions
0
Bought
0
Sold
2
Letters
Position history
Every position in EKF Diagnostics on record in the archive was reported in Q3 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 0 | 0 |
Fund activity · 1 position
- July 2026
Listed in Liontrust UK Smaller Companies Fund’s reported holdings.
Read the letterEKF Diagnostics
Also mentioned · 1
These funds discuss EKF Diagnostics — as a competitor, benchmark or comparable — without disclosing a position in it.
- MentionedRockwood strategic Harwood CapitalJuly 2026
“Christopher Mills - 45+ years investment experience, Chief Executive Officer and principal shareholder of Harwood Capital Management since 2011. He founded JO Hambro Capital Management with Jamie Hambro in 1993 acting as Chief Investment Officer and Harwood Wealth with Alan Durant in 2013 until their respective sales in 2011 and 2020. He is CEO of North Atlantic Smaller Companies Investment Trust (“NASCIT”) which he has managed since 1982 and Executive Director of Oryx International Growth Fund which he has managed since 1995. NASCIT has delivered a total NAV per share of nearly 200x under Mr. Mills’ management. He has sat on the Board of over 100 companies during his career including Augean, MJ Gleeson, Ten Entertainment, SureServe, Frenkel Topping and is currently Chairman of EKF Diagnostics and Renalytix Plc.”
Read the letterEKF Diagnostics
Read the letters behind these EKF Diagnostics positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger